Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Ethics, Evidence, and Cost in Newborn Screening
Link ID 7174
Title Ethics, Evidence, and Cost in Newborn Screening
Url http://www.medscape.com/viewarticle/574509?src=rss
Description What are the ethical and policy issues that arise in debates on public newborn screening programs? The experience in Mississippi serves to highlight an important ethical issue in child health policy.
The Hastings Center Report
Category Articles > Business of Medicine
Keywords
Date Jul 2, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Business of Medicine
1. Viread Approved for Treating Hepatitis B
  Gilead Sciences Inc said on Monday it won U.S. approval to promote its anti-HIV drug Viread (tenofovir) for treating adults with chronic hepatitis B. Reuters Health Information
Category:   Articles > Business of Medicine


2. FDA Approves Combination Niacin and Simvastatin
  Simcor is approved for use in patients with complex lipid abnormalities where treatment with niacin or simvastatin alone is not sufficient. Heartwire
Category:   Articles > Business of Medicine


3. New PML Cases Reported With Tysabri Monotherapy
  Natalizumab monotherapy is still believed to be safer than combination treatment with other immunomodulatory agents. Medscape Medical News
Category:   Articles > Business of Medicine


4. New FDA Orphan Drugs for Acute Chest Syndrome, Acute Recurrent Repetitive Seizures, Pouchitis
  The FDA has granted orphan drug designation to A-001 for the prevention of acute chest syndrome in patients with sickle cell disease, JZP-8 for the treatment of recurrent acute repetitive seizures in patients with epilepsy, and AST-120 for the treatment of pouchitis. Medscape Medical News
Category:   Articles > Business of Medicine


5. Using Population-based Routine Data for Evidence-based Health Policy Decisions: Lessons From Three E
  Three case studies, in national health policy from three countries: USA (prescription drug safety), Australia (childhood immunization) and UK (hospital waiting times) are presented.
Journal of Public Health
Category:   Articles > Business of Medicine




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS